Vital hepatitis in children and adolescence;Virale hepatitis bei kindern und jugendlichen

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 8, 2004, Pages 731-733

  Burdelski, M ^a   Wirth, S ^a   Laufs, R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS VACCINE; LAMIVUDINE; PEGINTERFERON; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN;

ADOLESCENT; CHILD; CHRONIC HEPATITIS; DELTA AGENT HEPATITIS; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; REVIEW; TREATMENT INDICATION; VACCINATION; VIRUS HEPATITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONSENSUS; GERMANY; HEPATITIS, VIRAL, HUMAN; HUMANS; PATIENT CARE MANAGEMENT; PRACTICE GUIDELINES;

EID: 4444329646     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813447     Document Type: Review

References (16)

1. Van Damme P, Vorsters A. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001. J Med Virol 2002; 67: 433-439 (Übersicht)
2. Ballistreros-Trujillo A, Vargas-Origel A, Alvarez-Munos T et al. Response to hepatitis B vaccine in preterm infants: four-dose schedule. Am J Perinatol 2001; 18: 379-385 (IIb)
3. Scheifele D. Universal childhood hepatitis B vaccination: infants vs adolescents, the Canadian perspective. Pediatr Infect Dis J 1998; 17: S35-S37 (Übersicht)
4. Wirth S, Wintermeyer P. Chronische Hepatitis B. In: Bassler D, Forster J, Antes G (Hrsg). Evidenz-basierte Pädiatrie. Praxisnahes EBM-Handbuch für pädiatrische Diagnostik und Therapie. Stuttgart: Thieme: 2-12 (Übersicht)
5. Wirth S. Hepatitis. In: DPGI-Handbuch. 4. Auflage. München: Futuramed, 2003 (Übersicht)
6. Bortolotti F, Jara P, Crivellaro C et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998; 29: 184-190 (III)
7. Deutsch J, Wirth S. Konsensus über die Behandlung der chronischen Hepatitis B im Kindesalter. Monatsschr Kinderheilkd 2002; 150: 625-629 (Übersicht)
8. Jara P, Bortolotti F. Interferon-(treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Ped Gastroenterol Nutr 1999; 29: 163-170 (Übersicht)
9. Dikici B, Bosnak M, Bosnak V et al. Comparison of treatments of chronic hepatitis B in children with lamivudine and alpha-interferon combination and alpha-interferon alone. Pediatr Int 2002; 44: 517-521 (III)
10. Jonas MM, Kelly DA, Mizerski J et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002; 346: 1703-1713 (Ib)
11. Polywka S, Schröter M, Feucht HH et al. Die vertikale Übertragung des Hepatitis C-Virus. Med Welt 2000; 51: 337-340 (Übersicht)
12. Tovo PA, Pembry IJ, Newell MC. European Paediatric Hepatitis C Virus Infection Network. J Inf Dis 2002; 181: 411-424 (Übersicht)
13. European Paediatric Hepatitis C Virus Infection Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C. Brit J Obstret Gynecol 2001; 108: 371-377 (Übersicht)
14. National Institutes of Health Consensus Development Conference Statement. Management of hepatitis C 2002. Gastroenterology 2002; 123: 2082-2090 (Übersicht)
15. Jacobson KR, Murray K, Zellos A et al. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Ped Gastroenterol Nutr 2003; 34: 52-58 (Ia)
16. Wirth S, Lang T, Gehring S et al. Recombinant (interferon plus ribaverin therapy in children and adolescents with chronic hepatitis C. Hepatology 2002; 36: 1280-1284 (IIb)